Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study

Aims To compare whether novel inflammatory and haemostatic biomarkers are more predictive of well-characterized incident acute coronary syndrome (ACS) than stable angina (SA). Methods and results We used data from the PRIME Study, a prospective cohort of 9758 asymptomatic middle-aged men recruited i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 2008-08, Vol.29 (16), p.1966-1974
Hauptverfasser: Empana, Jean-Philippe, Canoui-Poitrine, Florence, Luc, Gerald, Juhan-Vague, Irene, Morange, Pierre, Arveiler, Dominique, Ferrieres, Jean, Amouyel, Philippe, Bingham, Annie, Montaye, Michelle, Ruidavets, Jean-Bernard, Haas, Bernadette, Evans, Alun, Ducimetiere, Pierre
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1974
container_issue 16
container_start_page 1966
container_title European heart journal
container_volume 29
creator Empana, Jean-Philippe
Canoui-Poitrine, Florence
Luc, Gerald
Juhan-Vague, Irene
Morange, Pierre
Arveiler, Dominique
Ferrieres, Jean
Amouyel, Philippe
Bingham, Annie
Montaye, Michelle
Ruidavets, Jean-Bernard
Haas, Bernadette
Evans, Alun
Ducimetiere, Pierre
description Aims To compare whether novel inflammatory and haemostatic biomarkers are more predictive of well-characterized incident acute coronary syndrome (ACS) than stable angina (SA). Methods and results We used data from the PRIME Study, a prospective cohort of 9758 asymptomatic middle-aged men recruited in Northern Ireland and France between 1991 and 1993. A nested case–control study was established with the baseline plasma sample of 269 incident cases and 538 matched controls. Odds ratios (ORs) for SA and ACS were estimated by conditional logistic regression analysis. After 5 years of follow-up, 107 incident SA and 162 ACS cases were validated. After adjustment for traditional risk factors, higher circulating levels of hs-CRP, ICAM1, interleukin 6 and interleukin 18 were equally predictive of SA and ACS (all P-values of OR comparison >0.05). In contrast, elevated levels of fibrinogen, von Willebrand factor, and possibly higher level of D-dimers and lower level of tissue factor pathway inhibitor were associated with ACS only. The comparison of the ORs showed a statistically significant difference for von Willebrand factor only [OR4th vs. 1st quartile = 2.99 (1.49–6.02) for ACS vs. 0.80 (0.33–1.94) for SA; Pz test = 0.02]. Conclusion This is the first population-based study suggesting that higher levels of circulating haemostatic markers and of von Willebrand factor, in particular, are significantly more predictive of incident ACS than SA.
doi_str_mv 10.1093/eurheartj/ehn331
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04245062v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/eurheartj/ehn331</oup_id><sourcerecordid>69429061</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-763c8e2e858caec80baf1b72b6b74a95665d7d0abba9f1bc14a679605362aa1c3</originalsourceid><addsrcrecordid>eNqNkU1rGzEQhkVpadyk956K6KFQyjb6WGl3cwsmiQMOLUlKQi9C0o5juWvJlbSh_vdds8aFnnoamHnmHYYHoXeUfKGk4afQxyXomFensPSc0xdoQgVjRSNL8RJNCG1EIWX9eITepLQihNSSytfoiNaS0aqiE_Q0DT5HZ_rsgsdhgX14hg4bF9Y6_oSYcA7Yeeta8BmnrE0HWPsn5_VQWqxtnwHbEIPXcYvT1rcxrOEM5yXgb7fXNxf4Lvft9gS9Wuguwdt9PUbfLy_up7Ni_vXqeno-L6woSS4qyW0NDGpRWw22JkYvqKmYkaYqdSOkFG3VEm2MboaBpaWWVSOJ4JJpTS0_Rp_G3KXu1Ca64YutCtqp2flc7XqkZKUgkj3Tgf04spsYfvWQslq7ZKHrtIfQJyWbkjVE7sAP_4Cr0Ec__KEYFYLykssBIiNkY0gpwuJwnhK1s6UOttRoa1h5v8_tzRravwt7PQPweQRCv_mfuGKkXcrw-8APHpWseCXU7PGHuuGzh6tLWqsH_geZyLH9</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>215513436</pqid></control><display><type>article</type><title>Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Empana, Jean-Philippe ; Canoui-Poitrine, Florence ; Luc, Gerald ; Juhan-Vague, Irene ; Morange, Pierre ; Arveiler, Dominique ; Ferrieres, Jean ; Amouyel, Philippe ; Bingham, Annie ; Montaye, Michelle ; Ruidavets, Jean-Bernard ; Haas, Bernadette ; Evans, Alun ; Ducimetiere, Pierre</creator><creatorcontrib>Empana, Jean-Philippe ; Canoui-Poitrine, Florence ; Luc, Gerald ; Juhan-Vague, Irene ; Morange, Pierre ; Arveiler, Dominique ; Ferrieres, Jean ; Amouyel, Philippe ; Bingham, Annie ; Montaye, Michelle ; Ruidavets, Jean-Bernard ; Haas, Bernadette ; Evans, Alun ; Ducimetiere, Pierre ; PRIME Study Group ; on behalf of the PRIME Study Group</creatorcontrib><description>Aims To compare whether novel inflammatory and haemostatic biomarkers are more predictive of well-characterized incident acute coronary syndrome (ACS) than stable angina (SA). Methods and results We used data from the PRIME Study, a prospective cohort of 9758 asymptomatic middle-aged men recruited in Northern Ireland and France between 1991 and 1993. A nested case–control study was established with the baseline plasma sample of 269 incident cases and 538 matched controls. Odds ratios (ORs) for SA and ACS were estimated by conditional logistic regression analysis. After 5 years of follow-up, 107 incident SA and 162 ACS cases were validated. After adjustment for traditional risk factors, higher circulating levels of hs-CRP, ICAM1, interleukin 6 and interleukin 18 were equally predictive of SA and ACS (all P-values of OR comparison &gt;0.05). In contrast, elevated levels of fibrinogen, von Willebrand factor, and possibly higher level of D-dimers and lower level of tissue factor pathway inhibitor were associated with ACS only. The comparison of the ORs showed a statistically significant difference for von Willebrand factor only [OR4th vs. 1st quartile = 2.99 (1.49–6.02) for ACS vs. 0.80 (0.33–1.94) for SA; Pz test = 0.02]. Conclusion This is the first population-based study suggesting that higher levels of circulating haemostatic markers and of von Willebrand factor, in particular, are significantly more predictive of incident ACS than SA.</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehn331</identifier><identifier>PMID: 18621771</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Acute coronary syndrome ; Acute Coronary Syndrome - blood ; Acute Coronary Syndrome - diagnosis ; Acute Coronary Syndrome - etiology ; Angina pectoris ; Angina Pectoris - blood ; Angina Pectoris - diagnosis ; Angina Pectoris - etiology ; Atherothrombosis ; Biomarkers ; Biomarkers - analysis ; Biomarkers - blood ; Epidemiologic Methods ; Epidemiology ; Fibrin Fibrinogen Degradation Products - analysis ; Fibrinogen - analysis ; France ; Humans ; Life Sciences ; Lipoproteins - blood ; Male ; Middle Aged ; Myocardial Infarction - blood ; Myocardial Infarction - diagnosis ; Myocardial Infarction - etiology ; Northern Ireland ; von Willebrand Factor - analysis</subject><ispartof>European heart journal, 2008-08, Vol.29 (16), p.1966-1974</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org 2008</rights><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-763c8e2e858caec80baf1b72b6b74a95665d7d0abba9f1bc14a679605362aa1c3</citedby><cites>FETCH-LOGICAL-c540t-763c8e2e858caec80baf1b72b6b74a95665d7d0abba9f1bc14a679605362aa1c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18621771$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04245062$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Empana, Jean-Philippe</creatorcontrib><creatorcontrib>Canoui-Poitrine, Florence</creatorcontrib><creatorcontrib>Luc, Gerald</creatorcontrib><creatorcontrib>Juhan-Vague, Irene</creatorcontrib><creatorcontrib>Morange, Pierre</creatorcontrib><creatorcontrib>Arveiler, Dominique</creatorcontrib><creatorcontrib>Ferrieres, Jean</creatorcontrib><creatorcontrib>Amouyel, Philippe</creatorcontrib><creatorcontrib>Bingham, Annie</creatorcontrib><creatorcontrib>Montaye, Michelle</creatorcontrib><creatorcontrib>Ruidavets, Jean-Bernard</creatorcontrib><creatorcontrib>Haas, Bernadette</creatorcontrib><creatorcontrib>Evans, Alun</creatorcontrib><creatorcontrib>Ducimetiere, Pierre</creatorcontrib><creatorcontrib>PRIME Study Group</creatorcontrib><creatorcontrib>on behalf of the PRIME Study Group</creatorcontrib><title>Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study</title><title>European heart journal</title><addtitle>Eur Heart J</addtitle><description>Aims To compare whether novel inflammatory and haemostatic biomarkers are more predictive of well-characterized incident acute coronary syndrome (ACS) than stable angina (SA). Methods and results We used data from the PRIME Study, a prospective cohort of 9758 asymptomatic middle-aged men recruited in Northern Ireland and France between 1991 and 1993. A nested case–control study was established with the baseline plasma sample of 269 incident cases and 538 matched controls. Odds ratios (ORs) for SA and ACS were estimated by conditional logistic regression analysis. After 5 years of follow-up, 107 incident SA and 162 ACS cases were validated. After adjustment for traditional risk factors, higher circulating levels of hs-CRP, ICAM1, interleukin 6 and interleukin 18 were equally predictive of SA and ACS (all P-values of OR comparison &gt;0.05). In contrast, elevated levels of fibrinogen, von Willebrand factor, and possibly higher level of D-dimers and lower level of tissue factor pathway inhibitor were associated with ACS only. The comparison of the ORs showed a statistically significant difference for von Willebrand factor only [OR4th vs. 1st quartile = 2.99 (1.49–6.02) for ACS vs. 0.80 (0.33–1.94) for SA; Pz test = 0.02]. Conclusion This is the first population-based study suggesting that higher levels of circulating haemostatic markers and of von Willebrand factor, in particular, are significantly more predictive of incident ACS than SA.</description><subject>Acute coronary syndrome</subject><subject>Acute Coronary Syndrome - blood</subject><subject>Acute Coronary Syndrome - diagnosis</subject><subject>Acute Coronary Syndrome - etiology</subject><subject>Angina pectoris</subject><subject>Angina Pectoris - blood</subject><subject>Angina Pectoris - diagnosis</subject><subject>Angina Pectoris - etiology</subject><subject>Atherothrombosis</subject><subject>Biomarkers</subject><subject>Biomarkers - analysis</subject><subject>Biomarkers - blood</subject><subject>Epidemiologic Methods</subject><subject>Epidemiology</subject><subject>Fibrin Fibrinogen Degradation Products - analysis</subject><subject>Fibrinogen - analysis</subject><subject>France</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Lipoproteins - blood</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - blood</subject><subject>Myocardial Infarction - diagnosis</subject><subject>Myocardial Infarction - etiology</subject><subject>Northern Ireland</subject><subject>von Willebrand Factor - analysis</subject><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1rGzEQhkVpadyk956K6KFQyjb6WGl3cwsmiQMOLUlKQi9C0o5juWvJlbSh_vdds8aFnnoamHnmHYYHoXeUfKGk4afQxyXomFensPSc0xdoQgVjRSNL8RJNCG1EIWX9eITepLQihNSSytfoiNaS0aqiE_Q0DT5HZ_rsgsdhgX14hg4bF9Y6_oSYcA7Yeeta8BmnrE0HWPsn5_VQWqxtnwHbEIPXcYvT1rcxrOEM5yXgb7fXNxf4Lvft9gS9Wuguwdt9PUbfLy_up7Ni_vXqeno-L6woSS4qyW0NDGpRWw22JkYvqKmYkaYqdSOkFG3VEm2MboaBpaWWVSOJ4JJpTS0_Rp_G3KXu1Ca64YutCtqp2flc7XqkZKUgkj3Tgf04spsYfvWQslq7ZKHrtIfQJyWbkjVE7sAP_4Cr0Ec__KEYFYLykssBIiNkY0gpwuJwnhK1s6UOttRoa1h5v8_tzRravwt7PQPweQRCv_mfuGKkXcrw-8APHpWseCXU7PGHuuGzh6tLWqsH_geZyLH9</recordid><startdate>20080801</startdate><enddate>20080801</enddate><creator>Empana, Jean-Philippe</creator><creator>Canoui-Poitrine, Florence</creator><creator>Luc, Gerald</creator><creator>Juhan-Vague, Irene</creator><creator>Morange, Pierre</creator><creator>Arveiler, Dominique</creator><creator>Ferrieres, Jean</creator><creator>Amouyel, Philippe</creator><creator>Bingham, Annie</creator><creator>Montaye, Michelle</creator><creator>Ruidavets, Jean-Bernard</creator><creator>Haas, Bernadette</creator><creator>Evans, Alun</creator><creator>Ducimetiere, Pierre</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><general>Oxford University Press (OUP)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>7X8</scope><scope>1XC</scope></search><sort><creationdate>20080801</creationdate><title>Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study</title><author>Empana, Jean-Philippe ; Canoui-Poitrine, Florence ; Luc, Gerald ; Juhan-Vague, Irene ; Morange, Pierre ; Arveiler, Dominique ; Ferrieres, Jean ; Amouyel, Philippe ; Bingham, Annie ; Montaye, Michelle ; Ruidavets, Jean-Bernard ; Haas, Bernadette ; Evans, Alun ; Ducimetiere, Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-763c8e2e858caec80baf1b72b6b74a95665d7d0abba9f1bc14a679605362aa1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Acute coronary syndrome</topic><topic>Acute Coronary Syndrome - blood</topic><topic>Acute Coronary Syndrome - diagnosis</topic><topic>Acute Coronary Syndrome - etiology</topic><topic>Angina pectoris</topic><topic>Angina Pectoris - blood</topic><topic>Angina Pectoris - diagnosis</topic><topic>Angina Pectoris - etiology</topic><topic>Atherothrombosis</topic><topic>Biomarkers</topic><topic>Biomarkers - analysis</topic><topic>Biomarkers - blood</topic><topic>Epidemiologic Methods</topic><topic>Epidemiology</topic><topic>Fibrin Fibrinogen Degradation Products - analysis</topic><topic>Fibrinogen - analysis</topic><topic>France</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Lipoproteins - blood</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - blood</topic><topic>Myocardial Infarction - diagnosis</topic><topic>Myocardial Infarction - etiology</topic><topic>Northern Ireland</topic><topic>von Willebrand Factor - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Empana, Jean-Philippe</creatorcontrib><creatorcontrib>Canoui-Poitrine, Florence</creatorcontrib><creatorcontrib>Luc, Gerald</creatorcontrib><creatorcontrib>Juhan-Vague, Irene</creatorcontrib><creatorcontrib>Morange, Pierre</creatorcontrib><creatorcontrib>Arveiler, Dominique</creatorcontrib><creatorcontrib>Ferrieres, Jean</creatorcontrib><creatorcontrib>Amouyel, Philippe</creatorcontrib><creatorcontrib>Bingham, Annie</creatorcontrib><creatorcontrib>Montaye, Michelle</creatorcontrib><creatorcontrib>Ruidavets, Jean-Bernard</creatorcontrib><creatorcontrib>Haas, Bernadette</creatorcontrib><creatorcontrib>Evans, Alun</creatorcontrib><creatorcontrib>Ducimetiere, Pierre</creatorcontrib><creatorcontrib>PRIME Study Group</creatorcontrib><creatorcontrib>on behalf of the PRIME Study Group</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Empana, Jean-Philippe</au><au>Canoui-Poitrine, Florence</au><au>Luc, Gerald</au><au>Juhan-Vague, Irene</au><au>Morange, Pierre</au><au>Arveiler, Dominique</au><au>Ferrieres, Jean</au><au>Amouyel, Philippe</au><au>Bingham, Annie</au><au>Montaye, Michelle</au><au>Ruidavets, Jean-Bernard</au><au>Haas, Bernadette</au><au>Evans, Alun</au><au>Ducimetiere, Pierre</au><aucorp>PRIME Study Group</aucorp><aucorp>on behalf of the PRIME Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study</atitle><jtitle>European heart journal</jtitle><addtitle>Eur Heart J</addtitle><date>2008-08-01</date><risdate>2008</risdate><volume>29</volume><issue>16</issue><spage>1966</spage><epage>1974</epage><pages>1966-1974</pages><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Aims To compare whether novel inflammatory and haemostatic biomarkers are more predictive of well-characterized incident acute coronary syndrome (ACS) than stable angina (SA). Methods and results We used data from the PRIME Study, a prospective cohort of 9758 asymptomatic middle-aged men recruited in Northern Ireland and France between 1991 and 1993. A nested case–control study was established with the baseline plasma sample of 269 incident cases and 538 matched controls. Odds ratios (ORs) for SA and ACS were estimated by conditional logistic regression analysis. After 5 years of follow-up, 107 incident SA and 162 ACS cases were validated. After adjustment for traditional risk factors, higher circulating levels of hs-CRP, ICAM1, interleukin 6 and interleukin 18 were equally predictive of SA and ACS (all P-values of OR comparison &gt;0.05). In contrast, elevated levels of fibrinogen, von Willebrand factor, and possibly higher level of D-dimers and lower level of tissue factor pathway inhibitor were associated with ACS only. The comparison of the ORs showed a statistically significant difference for von Willebrand factor only [OR4th vs. 1st quartile = 2.99 (1.49–6.02) for ACS vs. 0.80 (0.33–1.94) for SA; Pz test = 0.02]. Conclusion This is the first population-based study suggesting that higher levels of circulating haemostatic markers and of von Willebrand factor, in particular, are significantly more predictive of incident ACS than SA.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>18621771</pmid><doi>10.1093/eurheartj/ehn331</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0195-668X
ispartof European heart journal, 2008-08, Vol.29 (16), p.1966-1974
issn 0195-668X
1522-9645
language eng
recordid cdi_hal_primary_oai_HAL_hal_04245062v1
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Acute coronary syndrome
Acute Coronary Syndrome - blood
Acute Coronary Syndrome - diagnosis
Acute Coronary Syndrome - etiology
Angina pectoris
Angina Pectoris - blood
Angina Pectoris - diagnosis
Angina Pectoris - etiology
Atherothrombosis
Biomarkers
Biomarkers - analysis
Biomarkers - blood
Epidemiologic Methods
Epidemiology
Fibrin Fibrinogen Degradation Products - analysis
Fibrinogen - analysis
France
Humans
Life Sciences
Lipoproteins - blood
Male
Middle Aged
Myocardial Infarction - blood
Myocardial Infarction - diagnosis
Myocardial Infarction - etiology
Northern Ireland
von Willebrand Factor - analysis
title Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T04%3A05%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Contribution%20of%20novel%20biomarkers%20to%20incident%20stable%20angina%20and%20acute%20coronary%20syndrome:%20the%20PRIME%20Study&rft.jtitle=European%20heart%20journal&rft.au=Empana,%20Jean-Philippe&rft.aucorp=PRIME%20Study%20Group&rft.date=2008-08-01&rft.volume=29&rft.issue=16&rft.spage=1966&rft.epage=1974&rft.pages=1966-1974&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehn331&rft_dat=%3Cproquest_hal_p%3E69429061%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=215513436&rft_id=info:pmid/18621771&rft_oup_id=10.1093/eurheartj/ehn331&rfr_iscdi=true